The Journal of Pharmaceutical Policy and Practice is the official journal of the Commonwealth Pharmacists Association.
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P21
Page 8 of 10
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P21
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P16
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O12
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):O11
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E4
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E3
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K3
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P3
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K2
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E2
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):E1
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):K1
Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P1
Retail drug sellers are a major source of health care and medicines in many countries. In Tanzania, drug shops are widely used, particularly in rural and underserved areas. Previously, the shops were allowed t...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:23
Nunavut is an Arctic territory in Canada subject to many social, economic and health disparities in comparison to the rest of the nation. The territory is affected by health care provision challenges caused by...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:22
Noncommunicable diseases are a major healthcare problem in Nepal and their burden is increasingevery year. Noncommunicable diseases (NCDs) bring additional challenges to the Nepalese healthcaresystem which is ...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:21
To examine parents’ preferences and willingness-to-pay (WTP) for HPV vaccines.
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:20
In 2007, the Sixtieth World Health Assembly (WHA) passed a resolution entitled “Better medicines for children” and subsequently the World Health Organization (WHO) recommended the inclusion of child-appropriat...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:19
The purpose of this study is to describe trends in the utilization of antihypertensive medications, overall and by type of medication, specifically thiazide diuretics, as well as uncontrolled hypertension, in ...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:17
To report the attitudes of community pharmacists in Kabul, Afghanistan, concerning the quality and price of locally manufactured medicines.
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:16
To explore the availability and utilization of the World Health Organization (WHO) recommended priority life-saving medicines for children under five in public health facilities in Uganda.
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:18
Taiwan’s National Health Insurance (NHI) has encouraged physicians to use “chronic medication prescriptions” for patients with stable chronic diseases since 1995. Patients are allowed to refill such prescripti...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:15
In the management of HIV infection, tenofovir is preferred to its predecessors – zidovudine and stavudine – in the antiretroviral therapy (ART) nucleoside backbone. Tenofovir’s (TDF) preference is based on its...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:14
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated the operation of the RDF and assessed whether there was interruption of supply of asthma medicine from 2008 to...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:12
Tanzania suffers a severe shortage of pharmaceutical staff. This negatively affects the provision of pharmaceutical services and access to medicines, particularly in rural areas. Task shifting has been propose...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:13
Generic medicine prescribing has become a common practice in public hospitals. However, the trend in private medical centres seems to be different. The objective of this study was to investigate knowledge, per...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:11
The Brazilian constitution guarantees the right to health, including access to medicines. In May 2004, Brazil’s government announced the “Farmácia Popular” Program (FPP) as a new mechanism to improve the Brazilia...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:10
Pharmaceutical supply chain is a significant component of the health system in supplying medicines, particularly in countries where main drugs are provided by local pharmaceutical companies. No previous studie...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:9
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:8
New antidiabetic medications such as insulin analogues and thiazolidinediones have been introduced over the last decade. This study compares the uptake of new agents in three emerging pharmaceutical markets: B...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:7
Patient access (or risk-sharing) schemes are alternative market access agreements between healthcare payers and medical product manufacturers for conditional coverage of promising health technologies. This stu...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:6
The formulation of pharmaceutical policy is a critical component of healthcare planning, made more important given that medicines are the ubiquitous technology in the diagnosis, treatment and prevention of dis...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:5
Across the world medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease. Pharmaceutical policy, as part of national health care policy, is concerned with the provision an...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:4
A key policy question for the government of Uganda is how to equitably allocate primary health care pharmaceutical budgets to districts. This paper seeks to identify variables influencing current primary healt...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:3
In 2007, the World Health Organization (WHO) launched the ‘make medicines child size’ (MMCS) campaign by urging countries to prioritize procurement of medicines with appropriate strengths for children’s age an...
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:2
To evaluate the determinants of compliance with national policies recommending Artemisinin Combination Therapy (ACT) for the treatment of uncomplicated malaria in the community.
Citation: Journal of Pharmaceutical Policy and Practice 2015 8:1
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O21
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O19
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O17
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O15
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P15
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O13
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P13
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O11
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P11
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O7
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O5
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O3
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P1
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O1
The Journal of Pharmaceutical Policy and Practice is the official journal of the Commonwealth Pharmacists Association.
Speed
81 days to first decision for reviewed manuscripts only
53 days to first decision for all manuscripts
130 days from submission to acceptance
34 days from acceptance to publication
Citation Impact
1.158 - Source Normalized Impact per Paper (SNIP)
0.644 - SCImago Journal Rank (SJR)
2.8 - CiteScore
Usage
358,077 Downloads
819 Altmetric mentions